Transcriptomic & Immune Microenvironment Profiling of Bladder Cancer Progression
OPPORTUNITYThe biology separating a contained bladder tumor from one that invades is unresolved, yet that single distinction drives entirely different treatment paths.
WHAT I BUILTA four-stage R pipeline — differential expression, functional enrichment, immune deconvolution, and longitudinal visualization — tracing molecular and immune change from pre-cancer to muscle-invasive disease.
IMPACTSurfaced an EMT/ECM remodeling signature at tumor onset and a TNF-driven inflammatory shift at invasion, plus immune-composition changes relevant to immunotherapy timing and patient selection.








